Zhijuan Kong

机构：Shandong Provincial Hospital, Shandong First Medical University · ORCID：0009-0001-0740-9525

发表论文 10 篇 · 总被引 299 次 · h-index 8

代表论文

• Mitochondrial metabolic reprogramming in diabetic kidney disease (2024 · Cell Death and Disease · 被引 123)
• T cells and their products in diabetic kidney disease (2023 · Frontiers in Immunology · 被引 65)
• Immune checkpoint inhibitors and acute kidney injury (2024 · Frontiers in Immunology · 被引 27)
• N6-methyladenosine methylation in kidney injury (2023 · Clinical Epigenetics · 被引 17)
• Acute kidney injury in patients treated with immune checkpoint inhibitors: a single-center retrospective study (2024 · Renal Failure · 被引 12)
• The inhibition of ZC3H13 attenuates G2/M arrest and apoptosis by alleviating NABP1 m6A modification in cisplatin-induced acute kidney injury (2025 · Cellular and Molecular Life Sciences · 被引 10)